This compound is primarily utilized in the field of medicinal chemistry and pharmacology. It serves as a key intermediate in the synthesis of various pharmaceutical agents, particularly those targeting neurological disorders. Its structure, featuring a trifluoromethoxy group, enhances the biological activity and stability of the resulting drugs. It is often employed in the development of compounds that interact with neurotransmitter systems, such as those involved in the treatment of depression, anxiety, and epilepsy. Additionally, its chiral nature allows for the creation of enantiomerically pure substances, which can improve drug efficacy and reduce side effects. Researchers also explore its potential in designing novel therapeutics for neurodegenerative diseases like Alzheimer's and Parkinson's.